IRIS
GIACOMELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.893
AS - Asia 11.826
EU - Europa 11.284
SA - Sud America 1.228
Continente sconosciuto - Info sul continente non disponibili 510
AF - Africa 154
OC - Oceania 33
Totale 46.928
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.576
SG - Singapore 4.829
CN - Cina 2.670
IE - Irlanda 2.539
RU - Federazione Russa 2.100
TR - Turchia 1.523
IT - Italia 1.273
SE - Svezia 1.148
HK - Hong Kong 1.123
DE - Germania 1.061
BR - Brasile 1.052
VN - Vietnam 945
UA - Ucraina 831
GB - Regno Unito 744
FR - Francia 606
FI - Finlandia 393
NL - Olanda 219
IN - India 218
CA - Canada 190
BD - Bangladesh 108
JP - Giappone 102
BE - Belgio 64
AR - Argentina 63
ES - Italia 56
MX - Messico 51
ZA - Sudafrica 50
PL - Polonia 41
IQ - Iraq 36
EU - Europa 34
ID - Indonesia 29
PK - Pakistan 28
RO - Romania 28
AU - Australia 24
CZ - Repubblica Ceca 24
LT - Lituania 23
CO - Colombia 22
EC - Ecuador 22
KR - Corea 22
MY - Malesia 22
VE - Venezuela 21
GR - Grecia 19
MA - Marocco 18
PH - Filippine 17
AT - Austria 16
CH - Svizzera 15
EG - Egitto 15
JM - Giamaica 15
NP - Nepal 15
CL - Cile 14
DZ - Algeria 14
PT - Portogallo 14
JO - Giordania 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
BG - Bulgaria 12
TN - Tunisia 12
CR - Costa Rica 11
PE - Perù 11
IL - Israele 10
AL - Albania 9
BO - Bolivia 9
HN - Honduras 9
KE - Kenya 9
LB - Libano 9
NZ - Nuova Zelanda 9
DK - Danimarca 8
PY - Paraguay 8
QA - Qatar 8
TH - Thailandia 8
ET - Etiopia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
HR - Croazia 6
HU - Ungheria 6
KZ - Kazakistan 6
MK - Macedonia 6
UY - Uruguay 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
IR - Iran 5
KW - Kuwait 5
NI - Nicaragua 5
RS - Serbia 5
TW - Taiwan 5
BB - Barbados 4
GE - Georgia 4
LV - Lettonia 4
NG - Nigeria 4
OM - Oman 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BS - Bahamas 3
BY - Bielorussia 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
PR - Porto Rico 3
Totale 46.414
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.347
Chandler 2.675
Singapore 2.582
Dublin 2.531
San Jose 2.069
Dallas 1.407
Ashburn 1.287
Hong Kong 1.103
Santa Clara 1.066
Boardman 995
Izmir 831
Council Bluffs 580
Nanjing 554
The Dalles 527
San Mateo 512
Wilmington 499
New York 461
Moscow 447
Lawrence 445
Princeton 444
Beijing 382
Ho Chi Minh City 292
Ann Arbor 291
Lauterbourg 253
Los Angeles 241
Nanchang 221
Hanoi 209
Milan 200
Amsterdam 177
L'aquila 164
L’Aquila 162
Dearborn 143
Woodbridge 137
Seattle 133
Verona 122
Hefei 121
Des Moines 119
Shenyang 119
São Paulo 112
Hebei 103
Tokyo 94
Kunming 90
Tianjin 90
Jiaxing 84
Frankfurt am Main 81
Shanghai 79
Munich 78
Rome 67
Mountain View 65
Helsinki 62
Columbus 61
Changsha 60
Dong Ket 60
Brussels 57
Jinan 57
Zhengzhou 56
Norwalk 55
Montreal 54
Phoenix 53
Chicago 48
Orem 48
Toronto 48
Philadelphia 45
Hangzhou 43
Houston 42
Da Nang 40
Haiphong 38
San Francisco 38
Pune 37
Rio de Janeiro 36
Ningbo 34
Brooklyn 33
Guangzhou 33
Warsaw 33
Atlanta 31
Johannesburg 31
Buffalo 29
London 29
Belo Horizonte 26
Chennai 26
Denver 25
Stockholm 25
Mumbai 24
Manchester 23
Charlotte 21
Kitzingen 21
Lanzhou 21
Brno 19
New Delhi 19
Pescara 19
Brasília 18
Boston 17
Bremen 17
Mexico City 17
Naples 17
Taizhou 17
Ankara 16
Bucharest 16
Redwood City 16
Falkenstein 15
Totale 30.517
Salva come PNG Salva come JPEG
Nome #
------- 351
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 285
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 205
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 186
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 184
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 176
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 163
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 161
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 158
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 158
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 156
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 155
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 155
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 155
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 151
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 149
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 148
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 146
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 146
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 145
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 145
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 144
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 144
Cardiovascular disease in primary sjögren’s syndrome 141
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 140
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 140
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 140
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 138
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 138
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 138
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 137
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 136
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 136
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 134
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 134
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 133
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 133
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 133
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 132
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 132
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 132
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis 132
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 130
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 129
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 129
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 129
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 128
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 128
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 128
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 127
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 126
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization 125
Stem cell therapies for systemic sclerosis 125
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 125
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 125
GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. 125
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 125
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 125
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 125
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study 124
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 124
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 123
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 123
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis 122
A comprehensive review on adult onset Still's disease 122
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 122
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 122
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 121
Malattie dell'apparato cardiovascolare 121
GAMMA/DELTA T CELL APOPTOSIS IN SYSTEMIC SCLEROSIS PATIENTS 121
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 120
ALTERAZIONI DELLE SOTTOPOLAZIONI LINFOCITARIE IN CORSO DI SCLERODERMIA 120
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 120
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 120
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 120
Combined approach to the initial stage raynaud’s phenomenon diagnosis by means of dynamic digital telehermograpy, capillaroscopy and pletismography. Preliminary findings. 119
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells 119
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. 119
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 119
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 119
Diagnostic and interventional radiology fundamentals of synovial pathology 119
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 119
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. 119
Cytokine production in patients with monoclonal gammapathies. 119
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 118
Inosine pranobex in the combination therapy of HIV infection. 118
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 118
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 118
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 118
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 118
DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. 117
 T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosi 117
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 117
Gamma-delta T cells are not involved in the natural and antibody-dependent cytotoxicity of peripheral blood mononuclear cells in inflammatory bowel disease. 117
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 117
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 117
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 116
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 116
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 116
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients 116
Totale 13.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 209.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 209.465
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.155 0 0 441 174 103 26 21 152 189 131 179 739
2022/20237.628 605 368 158 745 734 854 15 537 3.241 57 213 101
2023/20241.937 418 114 116 257 149 476 33 103 10 81 52 128
2024/20257.471 135 151 757 232 840 631 975 632 1.824 304 480 510
2025/202613.745 692 1.366 712 1.557 1.195 1.175 2.629 594 1.388 1.245 974 218
2026/20271.094 399 575 120 0 0 0 0 0 0 0 0 0
Totale 46.928